BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20809763)

  • 1. Susceptibility weighted magnetic resonance imaging of cerebral cavernous malformations: prospects, drawbacks, and first experience at ultra-high field strength (7-Tesla) magnetic resonance imaging.
    Dammann P; Barth M; Zhu Y; Maderwald S; Schlamann M; Ladd ME; Sure U
    Neurosurg Focus; 2010 Sep; 29(3):E5. PubMed ID: 20809763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The venous angioarchitecture of sporadic cerebral cavernous malformations: a susceptibility weighted imaging study at 7 T MRI.
    Dammann P; Wrede KH; Maderwald S; El Hindy N; Mueller O; Chen B; Zhu Y; Hütter BO; Ladd ME; Schlamann M; Sandalcioglu IE; Sure U
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):194-200. PubMed ID: 23085932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.
    Campbell PG; Jabbour P; Yadla S; Awad IA
    Neurosurg Focus; 2010 Sep; 29(3):E6. PubMed ID: 20809764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging.
    de Champfleur NM; Langlois C; Ankenbrandt WJ; Le Bars E; Leroy MA; Duffau H; Bonafé A; Jaffe J; Awad IA; Labauge P
    Neurosurgery; 2011 Mar; 68(3):641-7; discussion 647-8. PubMed ID: 21164377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral cavernous hemangiomas at 7 Tesla: initial experience.
    Schlamann M; Maderwald S; Becker W; Kraff O; Theysohn JM; Mueller O; Sure U; Wanke I; Ladd ME; Forsting M; Schaefer L; Gizewski ER
    Acad Radiol; 2010 Jan; 17(1):3-6. PubMed ID: 19910215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar cavernous malformation in pediatric patients: defining clinical, neuroimaging, and therapeutic characteristics.
    Knerlich-Lukoschus F; Steinbok P; Dunham C; Cochrane DD
    J Neurosurg Pediatr; 2015 Sep; 16(3):256-66. PubMed ID: 26053436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic imaging of hemangiomas in the brain].
    Toyoda K; Oba H
    Brain Nerve; 2011 Jan; 63(1):5-15. PubMed ID: 21228443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions.
    Shenkar R; Venkatasubramanian PN; Zhao JC; Batjer HH; Wyrwicz AM; Awad IA
    Neurosurgery; 2008 Oct; 63(4):782-9; discussion 789. PubMed ID: 18981890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility-weighted imaging in familial cerebral cavernous malformations.
    Cooper AD; Campeau NG; Meissner I
    Neurology; 2008 Jul; 71(5):382. PubMed ID: 18663188
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.
    Lehnhardt FG; von Smekal U; Rückriem B; Stenzel W; Neveling M; Heiss WD; Jacobs AH
    Arch Neurol; 2005 Apr; 62(4):653-8. PubMed ID: 15824268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging of cerebral cavernous malformations.
    Klostranec JM; Krings T
    J Neurosurg Sci; 2015 Sep; 59(3):221-35. PubMed ID: 25968928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical applications of 3.0 T magnetic resonance system in the neuroradiological field].
    Matsusue E; Ogawa T
    Brain Nerve; 2007 May; 59(5):479-85. PubMed ID: 17533973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved preoperative evaluation of cerebral cavernomas by high-field, high-resolution susceptibility-weighted magnetic resonance imaging at 3 Tesla: comparison with standard (1.5 T) magnetic resonance imaging and correlation with histopathological findings--preliminary results.
    Pinker K; Stavrou I; Szomolanyi P; Hoeftberger R; Weber M; Stadlbauer A; Noebauer-Huhmann IM; Knosp E; Trattnig S
    Invest Radiol; 2007 Jun; 42(6):346-51. PubMed ID: 17507804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pitfalls of conservative treatments of multiple probable cerebral cavernous malformations (CCMs): clinicopathological features of CCMs coexisting with vasculogenic mimicry in an anaplastic oligodendroglioma.
    Yamamoto J; Shimajiri S; Miyaoka R; Nishizawa S
    Brain Tumor Pathol; 2014 Jul; 31(3):215-21. PubMed ID: 24337536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.
    Washington CW; McCoy KE; Zipfel GJ
    Neurosurg Focus; 2010 Sep; 29(3):E7. PubMed ID: 20809765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are cavernous sinus hemangiomas and cavernous malformations different entities?
    Gonzalez LF; Lekovic GP; Eschbacher J; Coons S; Porter RW; Spetzler RF
    Neurosurg Focus; 2006 Jul; 21(1):e6. PubMed ID: 16859259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial lesions with high signal intensity on T1-weighted MR images: differential diagnosis.
    Ginat DT; Meyers SP
    Radiographics; 2012; 32(2):499-516. PubMed ID: 22411945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Imaging of Cerebral Cavernous Malformations: Computed Tomography and Magnetic Resonance Imaging.
    Mabray M; Hart B
    Methods Mol Biol; 2020; 2152():85-96. PubMed ID: 32524546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Developmental venous anomaly (DVA)].
    Zimmer A; Hagen T; Ahlhelm F; Viera J; Reith W; Schulte-Altedorneburg G
    Radiologe; 2007 Oct; 47(10):868, 870-4. PubMed ID: 17624510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
    Wolfsberger S; Ba-Ssalamah A; Pinker K; Mlynárik V; Czech T; Knosp E; Trattnig S
    J Neurosurg; 2004 Feb; 100(2):278-86. PubMed ID: 15086236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.